Correlation Between Molecular Partners and Pharvaris
Can any of the company-specific risk be diversified away by investing in both Molecular Partners and Pharvaris at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Molecular Partners and Pharvaris into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Molecular Partners AG and Pharvaris BV, you can compare the effects of market volatilities on Molecular Partners and Pharvaris and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Molecular Partners with a short position of Pharvaris. Check out your portfolio center. Please also check ongoing floating volatility patterns of Molecular Partners and Pharvaris.
Diversification Opportunities for Molecular Partners and Pharvaris
0.55 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Molecular and Pharvaris is 0.55. Overlapping area represents the amount of risk that can be diversified away by holding Molecular Partners AG and Pharvaris BV in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pharvaris BV and Molecular Partners is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Molecular Partners AG are associated (or correlated) with Pharvaris. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pharvaris BV has no effect on the direction of Molecular Partners i.e., Molecular Partners and Pharvaris go up and down completely randomly.
Pair Corralation between Molecular Partners and Pharvaris
Given the investment horizon of 90 days Molecular Partners AG is expected to generate 1.01 times more return on investment than Pharvaris. However, Molecular Partners is 1.01 times more volatile than Pharvaris BV. It trades about -0.04 of its potential returns per unit of risk. Pharvaris BV is currently generating about -0.1 per unit of risk. If you would invest 606.00 in Molecular Partners AG on November 2, 2024 and sell it today you would lose (83.00) from holding Molecular Partners AG or give up 13.7% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Molecular Partners AG vs. Pharvaris BV
Performance |
| Timeline |
| Molecular Partners |
| Pharvaris BV |
Molecular Partners and Pharvaris Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Molecular Partners and Pharvaris
The main advantage of trading using opposite Molecular Partners and Pharvaris positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Molecular Partners position performs unexpectedly, Pharvaris can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pharvaris will offset losses from the drop in Pharvaris' long position.| Molecular Partners vs. Mineralys Therapeutics, Common | Molecular Partners vs. AN2 Therapeutics | Molecular Partners vs. Pharvaris BV | Molecular Partners vs. PepGen |
| Pharvaris vs. Pmv Pharmaceuticals | Pharvaris vs. MediciNova | Pharvaris vs. PepGen | Pharvaris vs. Molecular Partners AG |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |